Related Experiment Video
Updated: Aug 2, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection
Lauren Bitterman1, Mahdis Solhjoo1, Vivek Shah1
1Loma Linda University Medical Center, CA, USA.
Abstract:
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome. We present a case in which antiphospholipid antibodies were detected in the presence of significant thromboses. The patient was subsequently treated for suspected catastrophic antiphospholipid syndrome following COVID-19 infection.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis

